Quill & Scope
Volume 4 Volume IV

Article 4

2011

A Nutty Approach to Disease Prevention
Amin Esfahani
New York Medical College

Follow this and additional works at: https://touroscholar.touro.edu/quill_and_scope
Part of the Arts and Humanities Commons, Higher Education Commons, and the Medicine and Health
Sciences Commons

Recommended Citation
Esfahani, A. (2011). A Nutty Approach to Disease Prevention. Quill & Scope, 4 (1). Retrieved from

This Review is brought to you for free and open access by the Students at Touro Scholar. It has been accepted for
inclusion in Quill & Scope by an authorized editor of Touro Scholar. . For more information, please contact
touro.scholar@touro.edu.

A Nutty Approach to Disease Prevention
Amin Esfahani

INTRODUCTION
The prevalence of type 2 diabetes has increased dramatically over the past three decades and current
estimates predict a further 50% increase worldwide by the year 2030.1 Diabetes is associated with
numerous micro- and macrovascular complications including, blindness, kidney failure and limb
amputation.2 Furthermore, the presence of diabetes increases the risk of cardiovascular disease (CVD)
two to five fold, especially for women.3,4 Alongside the current global obesity epidemic5,6, the increase
in prevalence of diabetes is going to further strain the already-overburdened healthcare system of United
States and potentially prove catastrophic for nations with limited resources.
While there is no available cure for diabetes, studies have shown that primary prevention can be
attained through modifications to diet and lifestyle. Unfortunately, with mass media as a vehicle, the
general public, for the most part, has been exposed to “fad diets” and “magic bullets” that not only lead
to no metabolic benefits but may in fact, in some circumstances, prove harmful by depriving the body of
many essential nutrients. These “quick-to-fix” approaches have drawn the attention away from the
traditional staples of human diet such as whole grains, fruit, green leafy vegetable, seeds and nuts which
have been linked by scientific evidence to a reduced risk of a number of chronic diseases including
diabetes and CVD.7 The purpose of this paper is to 1) provide a brief overview of the current evidence
linking tree nuts to the risk of diabetes and heart disease and 2) to outline some of the key challenges for
recommending nuts as part of a healthy diet to patients with or at risk of diabetes or heart disease.
TREE NUTS
The term, “nut”, encompasses a wide range of
seeds that based strictly on botanical definitions are
not actually nuts. While hazelnuts meet the botanical
definition, almonds, pistachios and walnuts which are
all seeds of drupe fruits, do not. Despite this
inconsistency, the aforementioned seeds, along with
hazelnuts, pine nuts, pecans, cashews, Brazils, and
macadamias have been clustered together under the
collective term, “tree nuts” by the International Tree
Nut Council.8

...tree nuts as a whole
are healthy foods because
of favorable fatty acid
profile… as well as being
good sources of protein,
fiber, phytosterols,
polyphenols, vitamins
and minerals.”

Until recently, in Western societies, nuts were
considered to be high fat and as such, contraindicated
in therapeutic diets. However, scientific evidence in
the past decade has changed this negative perception.
Despite small variations in their micro- and
macronutrient profiles, tree nuts as a whole are healthy
foods because of their favorable fatty acid profile (low
in saturated fats and high in mono- and polyunsaturated fats [MUFAs and PUFAs respectively]). They
are also low in available carbohydrate content, as well as being good sources of vegetable protein, fiber,
phytosterols, polyphenols, vitamins and minerals. Table 1 summarizes the micro- and macronutrient
profile of some commonly consumed nuts. Nuts may therefore be a useful component of a dietary strategy aimed improving the risk factors of diabetes and CVD.
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Table 1 Nutritional profile of commonly consumed, whole, natural nuts (per ounce)

Almonds

Cashews

Pecans

Pistachios

Walnuts

23

18

19 halves

49

14 halves

160

160

200

160

190

Protein, g

6

4

3

6

4

Carbohydrates, by difference, g

6

9

4

8

4

4

1

3

3

2

14

13

20

13

18

Saturated fatty acids, g

1

3

2

1.5

1.5

Monounsaturated fatty acids, g

9

8

12

7

2.5

3.5

2

6

4

13

0

0

0

0

0

Calcium

75 (8)

13(0)

20(2)

31 (3)

28 (2)

Iron

1.1 (6)

1.7 (10)

0.7 (4)

1.2 (6)

0.8 (4)

0 (0)

5 (0)

0 (0)

3 (0)

1 (0)

Potassium

200 (6)

160 (4)

116 (4)

295 (9)

125 (4)

Magnesium

76 (20)

74 (20)

34 (8)

34 (8)

45 (10)

Phosphorus

137 (15)

139 (15)

79 (8)

137 (15)

98 (10)

Zinc

0.9 (6)

1.6 (10)

1.3 (8)

0.6 (4)

0.9 (6)

Manganese

0.7 (30)

0.2 (10)

1.3 (60)

0.4 (20)

1.0 (50)

Copper

0.2 (15)

0.6 (30)

0.3 (15)

0.4 (20)

0.5 (25)

Selenium, mcg

0.7 (0)

3.3 (4)

1.1 (2)

2.6 (4)

1.4 (2)

Thiamin

0.06 (4)

0.06 (4)

0.19 (10)

0.24 (15)

0.1 (6)

Riboflavin

0.3 (15)

0.06 (4)

0.04 (2)

0.05 (2)

0.04 (2)

Niacin

1.0 (4)

0.4 (2)

0.3 (2)

0.4 (2)

0.3 (2)

Vitamin B-6, g

0.04 (2)

0.07 (4)

0.06 (2)

0.36 (20)

0.15 (8)

Folate, total, g

14 (4)

20 (4)

6 (2)

14 (4)

28 (6)

(35)

(0)

(2)

(2)

(0)

Number of Kernels per Ounce
Total Energy, kcal

Fiber, total dietary, g
Total Lipids

Polyunsaturated fatty acids, g
Cholesterol
Minerals, mg* (% DV)

Sodium

Vitamins, mg* (% DV)

Vitamin E (total tocopherols)

Modified from tables prepared by the International Tree Nut Council8, accessed on January 15, 2011. The values
are for unsalted, unroasted nuts (except for cashews and pistachios which were dry roasted)*mg (miligram); %DV
= % daily value
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NUTS & HEART DISEASE
The protective effect of nuts in relation to the risk of CVD has been demonstrated in a number of
cohort studies. A pooled-analysis of the results from four major cohorts9-12 (sample size of over 170,000
individuals) demonstrated that in comparison to little or no nut consumption, the highest intake group
for nut consumption (4 or more servings per week) had a statistically significant reduction of
approximately 35% in the risk of developing coronary heart disease (CHD).13
Clinical interventions have supported the findings of the aforementioned cohort studies and have
shed light on potential mechanisms of action. The dietary interventional studies have shown that nut
consumption can reduce the risk of heart disease by improving serum lipid profile, endothelial function,
and blood pressure, in addition to lowering oxidative stress, and inflammation.14 Two systematic
reviews showed that the intake of 1.5 to 3.5 ounces of nuts, 5 or more times per week, can reduce LDLcholesterol (LDL-C) 3-19% in comparison to Western or lower fat diets.15,16 Meta-analyses of clinical
trials involving almonds or walnuts have demonstrated that both are effective in significantly lowering
Total-C and LDL-C.17,18 Furthermore, despite the absence of a pooled analysis, the results from 4 clinical trials show that the intake of 2 to 3.5 ounces (approximately 50 kernels/oz) of pistachios per day
increased serum HDL-C levels.19-22 The strength of the evidence has prompted the United States Food
and Drug Agency (USFDA) to approve a qualified health claim for nuts and serum cholesterol
reduction.
NUTS AND TYPE 2 DIABETES
While the current evidence demonstrates that the frequent intake of nuts is protective against heart
disease, the effect of nuts on the risk of developing type 2 diabetes is not as conclusive. Of the two
cohort studies on this topic, one showed a 27% reduction in the relative risk of developing diabetes in
individuals who consumed nuts five or more times per week compared with those who rarely or never
ate nuts23, while the other did not show a link between nut/peanut intake and the risk of type 2
diabetes.24
Despite the inconsistency in the epidemiological evidence, there are a number of plausible
mechanisms that suggest a potential protective effect for nuts against the risk of type 2 diabetes. The first relates to the low available carbohydrate content of nuts (Table 1). Adequate glycemic control is crucial
for prevention and management of type 2 diabetes.25 A number of acute studies have shown that almonds are capable of improving post-meal glyciemic control through low post-meal glucose and insulin responses.26, 27 Both of these parameters have been linked to improved insulin sensitivity, prevention
of hyperinsulinemia and overall, improved glycemic control in patients with type 2 diabetes.28 However, despite plausible evidence it is not clear if improvements in acute glycemia are indicative of long
term changes in insulin resistance. Moreover, the limited number of long-term clinical trials in this area
have been inconclusive, with some showing benefits in fasting insulin and glucose and others showing
no effect.29 Worth noting is that no study to date has shown improvements in HbA1c (established marker
of long-term glycemic control). However, these long-term term trials have had a number of limitations,
which have been outlined in other publications.14
Several other lesser studied mechanisms for reducing the risk of diabetes include: reduction in inflammation30, which has been linked to the risk of diabetes and heart disease31, or improvement in
glycemic control through displacement of carbohydrates with MUFAs (high in nuts)32. Finally, a recent
meta-analysis of the prospective studies showed that a 100mg per day increase in dietary magnesium
intake reduced the risk of developing diabetes by 14%.33 Nuts are good sources of magnesium (Table 1).
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The current body of scientific research demonstrates that nuts may have a modest beneficial effect
on serum lipids and markers of glycemia in subjects with type 2 diabetes.14, 34 Therefore, the moderate
use of nuts as a part of a healthy diet and in very high risk populations alongside medication may help
better manage diabetes. Furthermore, while the assessment of long-term effect of nuts in prevention and
management of diabetes is required, due to the potentially favourable effects on glycemia and
inflammation intake of nuts may benefit those at risk of developing diabetes.
KEY CHALLENGES
There are a number of concerns associated with recommending the intake of nuts to high risk populations (e.g. patients with diabetes). Food allergy is one of these concerns. Currently, 0.4% of the US
population are allergic to tree nuts (most prevalent allergies are those to walnuts, cashews and
almonds).35 This type of allergy is a major contributor to the overall 100-200 annual deaths that result
from food-induced anaphylaxis.36
There are also several important research areas that need to be addressed when assessing the impact
of nuts on health outcomes. One is the aforementioned, long term effect on markers of diabetes. Another
has to do with the fact that despite similarities, there are still differences in micro- and macronutrient
profiles of specific nuts, which may lead to different metabolic effects. Therefore, more trials need to be
conducted using the “lesser-studied” tree nuts in order to determine whether they generate comparable
metabolic benefits to almonds, walnuts and pistachios (the “more studied” tree nuts). Furthermore, the
efficacy of mixed-nut diets should also be examined. Finally, dose-response studies should be
conducted, in order to determine the ideal intake levels for maximal metabolic benefits and to also
establish detrimental doses.
The most common cited concerns with nut consumption are their high fat content and energy
density, which some fear will lead to weight gain and consequently, obesity. However, the overall
evidence from epidemiological studies not only shows no association between nut intake and weight
gain, but it in fact points to an inverse trend.37 Furthermore, evidence suggests that in the context of
energy-restricted diets, the addition of nuts generates a more lasting and greater magnitude of weight
loss among obese subjects.38 One mechanism of action that has been studied in almonds, suggests that
the cell walls of almonds decrease the bioaccessibility of lipids by hindering their availability for
digestion.39 However, more clinical trials are required to assess the impact of nuts on weight loss and if
applicable, to help determine the potential mechanisms of action. Overall, addressing these key
challenges will allow governing agencies to make better recommendations to the general public.
CONCLUSION
Tree nuts on their own are not “magic bullets” that will prevent chronic diseases. However, the
current body of scientific evidence shows that their addition to healthy diets leads to additional
metabolic benefits. For instance, the addition of nuts to a vegan-diet rich in plant sterols, vegetable proteins and soluble fiber led to reductions in LDL-C similar to those obtained with starting doses of Statin
medication.40 Furthermore, their inclusion in the Mediterranean or weight loss diets has improved the
efficacy of these diets in comparison to the currently recommended therapeutic diets.41-43 Overall, the
intake of nuts as part of a healthy diet can improve risk factors of heart disease, short-term glycemic
control and to a limited extent enhance weight loss. As such, in lieu of their energy density, healthy
individuals and those at high risk of type 2 diabetes and/or heart disease will benefit from the inclusion
of nuts in their diets.
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